The Huntington Study Group announces first-HD study ( Boston University Medical Center ) The Huntington Study Group, under the leadership of Samuel Frank, MD, Principal Investigator, and Claudia Testa, MD, PhD, co-Principal Investigator, is conducting a clinical trial with a formulation of the novel drug SD-809 in the treatment of HD the United States and Canada. The trial is sponsored by Auspex Pharmaceuticals, Inc. who is developing the drug ...
June 21, 2013 - EurekAlert!